Cardihab being used in a world leading long COVID study
Today the Baker Heart and Diabetes Institute announced a world leading investigation into the long-term heart damage caused by COVID-19. Hundreds of Melbourne COVID-19 survivors are being recruited for the study looking into the effects of what is dubbed "long COVID" — where those who have previously tested positive report complications months after they have recovered.
We are incredibly proud that the Cardihab platform will be utilised in this study to support patients in their disease management and recovery.
Read the announcement on 9News:
For more information on the study please visit the Baker Institute website: https://lnkd.in/gfSchpV
